Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 2 |
2015 | 4 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Showing results for
seungsuh hong
Your search for
SeungEui Hong
retrieved no results
Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13).
Expert Rev Clin Immunol. 2015;11 Suppl 1:S33-41. doi: 10.1586/1744666X.2015.1090312.
Expert Rev Clin Immunol. 2015.
PMID: 26395835
Review.
Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13.
Schreiber S, Panés J, Kwon B, Hong S, Peyrin-Biroulet L.
Schreiber S, et al. Among authors: hong s.
Expert Rev Gastroenterol Hepatol. 2015;9 Suppl 1:5-15. doi: 10.1586/17474124.2015.1091304.
Expert Rev Gastroenterol Hepatol. 2015.
PMID: 26395530
Review.
Item in Clipboard
Scientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in Europe.
Müller-Ladner U, Hong S, Oh C, Taylor P.
Müller-Ladner U, et al. Among authors: hong s.
Expert Rev Clin Immunol. 2015;11 Suppl 1:S5-14. doi: 10.1586/1744666X.2015.1090310.
Expert Rev Clin Immunol. 2015.
PMID: 26395832
Review.
Item in Clipboard
Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.
Shin EC, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong SS, Park JH.
Shin EC, et al.
Exp Mol Med. 2002 May 31;34(2):114-22. doi: 10.1038/emm.2002.17.
Exp Mol Med. 2002.
PMID: 12085986
Item in Clipboard
Cooperative action of alpha-glucanotransferase and maltogenic amylase for an improved process of isomaltooligosaccharide (IMO) production.
Lee HS, Auh JH, Yoon HG, Kim MJ, Park JH, Hong SS, Kang MH, Kim TJ, Moon TW, Kim JW, Park KH.
Lee HS, et al.
J Agric Food Chem. 2002 May 8;50(10):2812-7. doi: 10.1021/jf011529y.
J Agric Food Chem. 2002.
PMID: 11982404
Item in Clipboard
Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product.
Yoo DH, Oh C, Hong S, Park W.
Yoo DH, et al. Among authors: hong s.
Expert Rev Clin Immunol. 2015;11 Suppl 1:S15-24. doi: 10.1586/1744666X.2015.1090314.
Expert Rev Clin Immunol. 2015.
PMID: 26395833
Item in Clipboard
Cite
Cite